Incannex Healthcare Inc.

IXHL Biotech & pharma

Develops oral therapies for obstructive sleep apnea and anxiety disorders.

Jun 2026Revenue $0.00/yrExpenses $23.0M/yr
No trendCash runway ≈ 5.3 years from Jun 2026
Figures by year

When will Incannex Healthcare be profitable?

Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $0.00 and expenses $23.0M.

Fiscal year toRevenueExpensesOperating profit
Jun 2026$0.00$23.0M−$23.0M
Jun 2025$86.0K$23.9M−$23.8M
Jun 2024$12.0K$30.1M−$30.0M